Model selection for assessing the effects of doxorubicin on triple-negative breast cancer cell lines (Q2105797): Difference between revisions
From MaRDI portal
ReferenceBot (talk | contribs) Changed an Item |
Normalize DOI. |
||
| Property / DOI | |||
| Property / DOI: 10.1007/s00285-022-01828-x / rank | |||
| Property / DOI | |||
| Property / DOI: 10.1007/S00285-022-01828-X / rank | |||
Normal rank | |||
Latest revision as of 01:56, 17 December 2024
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Model selection for assessing the effects of doxorubicin on triple-negative breast cancer cell lines |
scientific article |
Statements
Model selection for assessing the effects of doxorubicin on triple-negative breast cancer cell lines (English)
0 references
8 December 2022
0 references
tumor growth
0 references
doxorubicin
0 references
mathematical modeling
0 references
Bayesian calibration
0 references
0 references
0 references
